Compare AURA & AVBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | AVBH |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.4M | 288.4M |
| IPO Year | 2021 | N/A |
| Metric | AURA | AVBH |
|---|---|---|
| Price | $5.61 | $28.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $20.20 | ★ $33.00 |
| AVG Volume (30 Days) | ★ 206.1K | 67.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $339.46 |
| Revenue Next Year | N/A | $11.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.73 | $22.95 |
| 52 Week High | $7.73 | $31.61 |
| Indicator | AURA | AVBH |
|---|---|---|
| Relative Strength Index (RSI) | 47.84 | 35.47 |
| Support Level | $5.08 | $26.93 |
| Resistance Level | $6.11 | $27.99 |
| Average True Range (ATR) | 0.37 | 1.01 |
| MACD | -0.02 | -0.29 |
| Stochastic Oscillator | 46.32 | 21.43 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.